Abstrakt

Przypisy

• 1. Albert C.M., Cook N.R., Gaziano J.M., Zaharris E., MacFadyen J.,Danielson E., Buring J.E., Manson J.E.: Effect of folic acid and B vitaminson risk of cardiovascular events and total mortality amongwomen at high risk for cardiovascular disease: a randomized trial.JAMA, 2008; 299: 2027-2036
  Google Scholar
• 2. Alian Z., Hashemipour M., Dehkordi E.H., Hovsepian S., Amini M.,Moadab M.H., Javanmard S.H.: The effects of folic acid on markersof endothelial function in patients with type 1 diabetes mellitus.Med. Arh., 2012; 66: 12-15
  Google Scholar
• 3. Baszczuk A., Kopczyński Z., Pupek-MusialikD., Czeryba M., KopczyńskiJ., Cymerys M., Thielemann A.: Ocena stężenia białka C-reaktywnegow surowicy chorych na pierwotne nadciśnienie tętniczez hiperhomocysteinemią. Nadciś. Tęt., 2009; 13: 167-174
  Google Scholar
• 4. Baszczuk A., Kopczyński Z., Thielemann A.: Dysfunkcja śródbłonkanaczyniowego u chorych na pierwotne nadciśnienie tętniczez hiperhomocysteinemią. Postępy Hig. Med. Dośw., 2014; 68: 91-100
  Google Scholar
• 5. Bleie Ø., Semb A.G., Grundt H., Nordrehaug J.E., Vollset S.E.,Ueland P.M., Nilsen D.W., Bakken A.M., Refsum H., Nygård O.K.: Homocysteine-lowering therapy does not affect inflammatory markersof atherosclerosis in patients with stable coronary artery disease. J.Intern. Med., 2007; 262: 244-253
  Google Scholar
• 6. Bogdański P., Pupek-Musialik D., Dytfeld J., Lacinski M., JabłeckaA., Jakubowski H.: Plasma homocysteine is a determinant of tissuenecrosis factor-α in hypertensive patients. Biomed. Pharmacother.,2008; 62: 360-365
  Google Scholar
• 7. Bolewski A., Plewa R., Siminiak T.: Udział czynników zapalnychw patogenezie miażdżycy. Pol. Przegl. Kard., 2003; 5: 61-69
  Google Scholar
• 8. Bønaa K.H., Njølstad I., Ueland P.M., Schirmer H., Tverdal A.,Steigen T., Wang H., Nordrehaug J.E., Arnesen E., Rasmussen K.,NORVIT Trial Investigators: Homocysteine lowering and cardiovascularevents after acute myocardial infarction. N. Engl. J. Med.,2006; 354: 1578-1588
  Google Scholar
• 9. Cheng Z., Yang X., Wang H.: Hyperhomocysteinemia and endothelialdysfunction. Curr. Hypertens. Rev., 2009; 5: 158-165
  Google Scholar
• 10. Damnjanović G., Jelić M., Dindić B., Ilić S.: Serum concentrationof solube adhesive molecules in patients with different forms ofcoronary artery disease. Vojnosanit. Pregl., 2009; 66: 265-270
  Google Scholar
• 11. Davey Smith G., Lawlor D.A., Harbord R., Timpson N., RumleyA., Lowe G.D., Day I.N., Ebrahim S.: Association of C-reactive proteinwith blood pressure and hypertension: life course confounding andmendelian randomization tests of causality. Arterioscler. Tromb.Vasc. Biol., 2005; 25: 1051-1056
  Google Scholar
• 12. Domagała T.B.: Kwas foliowy – homocysteina a choroba niedokrwiennaserca. Kardiol. Pol., 2004; 60: 66-70
  Google Scholar
• 13. Ebbing M., Bleie Ø., Ueland P.M., Nordrehaug J.E., Nilsen D.W.,Vollset S.E., Refsum H., Pedersen E.K., Nygård O.: Mortality and cardiovascularevents in patients treated with homocysteine-loweringB vitamins after coronary angiography: a randomized controlledtrial. JAMA, 2008; 300: 795-804
  Google Scholar
• 14. Gariballa S., Afandi B., Abuhaltem M., Yassin J., Habib H., IbrahimW.: Oxidative damage and inflammation in obese diabetic Emiratisubjects supplemented with antioxidants and B-vitamins: a randomizedplacebo-controlled trail. Nutr. Metab., 2013; 10: 21
  Google Scholar
• 15. Hirschfield G.M., Pepys M.B.: C-reactive protein and cardiovasculardisease: new insights from an old molecule. Q. J. Med., 2003;96: 793-807
  Google Scholar
• 16. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., TanjiN., Ferran L.J.Jr, Kohl B., Rao V., Kisiel W., Stern D.M., Schmidt A.M.:Hyperhomocysteinemia enhances vascular inflammation and acceleratesatherosclerosis in a murine model. J. Clin. Invest., 2001;107: 675-683
  Google Scholar
• 17. Jakubowski H.: Homocysteine is a protein amino acid in humans.Implications for homocysteine-linked disease. J. Biol. Chem.,2002; 277: 30425-30428
  Google Scholar
• 18. King D.E., Egan B.M., Mainous A.G.3rd, Geesey M.E.: Elevation ofC-reactive protein in people with prehypertension. J. Clin. Hypertens.,2004; 6: 562-568
  Google Scholar
• 19. Klerk M., Durga J., Schouten E.G., Kluft C., Kok F.J., Verhoef P.:No effect of folic acid supplementation in the course of 1 year onhaemostasis markers and C-reactive protein in older adults. Thromb.Haemost., 2005; 94: 96-100
  Google Scholar
• 20. Lee H., Kim H.J., Kim J.M., Chang N.: Effects of dietary folic acidsupplementation on cerebrovascular endothelial dysfunction in ratswith induced hyperhomocysteinemia. Brain Res., 2004; 996: 139-147
  Google Scholar
• 21. Li M., Chen J., Li Y.S., Feng Y.B., Gu X., Shi C.Z.: Folic acid reducesadhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia.Int. J. Cardiol., 2006; 106: 285-288
  Google Scholar
• 22. Martin J., Collot-Teixeira S., McGregor L., McGregor J.L.: Thedialogue between endothelial cells and monocytes/macrophages invascular syndromes. Curr. Pharm. Des., 2007; 13:1751-1759
  Google Scholar
• 23. Mierzecki A., Kłoda K., Jastrzębska M., Chełstowski K., HonczarenkoK., Kozłowska-Wojciechowska M., Naruszewicz M.: Is there aneffect of folic acid supplementation on the coagulation factors andC-reactive protein concentrations in subjects with atherosclerosisrisk factors? Postępy Hig. Med. Dośw., 2012; 66: 696-701
  Google Scholar
• 24. O’Doherty M.G., Gilchrist S.E., Young I.S., McKinley M.C., YarnellJ.W., Gey K.F., Evans A., Skidmore P.M., Woodside J.V.: Effect of supplementationwith B vitamins and antioxidants on levels of asymmetricdimethylarginine (ADMA) and C-reactive protein (CRP): a double–blind, randomised, factorial design, placebo-controlled trial. Eur.J. Nutr., 2010; 49: 483-492
  Google Scholar
• 25. Ridker P.M., Stampfer M.J., Rifai N.: Novel risk factors for systemicatherosclerosis: a comparison of C-reactive protein, fibrinogen,homocysteine, lipoprotein(a), and standard cholesterol screening aspredictors of peripheral arterial disease. JAMA, 2001; 285: 2481-2485
  Google Scholar
• 26. Scheurig A.C., Thorand B., Fischer B., Heier M., Koenig W.: Associationbetween the intake of vitamins and trace elements fromsupplements and C-reactive protein: results of the MONICA/KORAAugsburg study. Eur. J. Clin. Nutr., 2008; 62: 127-137
  Google Scholar
• 27. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., RidkerP.M.: C-reactive protein and the risk of developing hypertension.JAMA, 2003; 290: 2945-2951
  Google Scholar
• 28. Shai I., Stampfer M.J., Ma J., Manson J.E., Hankinson S.E., CannuscioC., Selhub J., Curhan G., Rimm E.B.: Homocysteine as a riskfactor for coronary heart diseases and its association with inflammatorybiomarkers, lipids and dietary factors. Atherosclerosis, 2004;177: 375-381
  Google Scholar
• 29. Spence J.D., Stampfer M.J.: Understanding the complexity of homocysteinelowering with vitamins: the potential role of subgroupanalyses. JAMA, 2011; 306: 2610-2611
  Google Scholar
• 30. Sung F.L., Slow Y.L., Wang G., Lynn E.G., O K.: Homocysteinestimulates the expression of monocyte chemoattractant protein-1in endothelial cells leading to enhanced monocyte chemotaxis. Mol.Cell. Biochem., 2001; 216: 121-128
  Google Scholar
• 31. Verma S., Kuliszewski M.A., Li S.H., Szmitko P.E., Zucco L., WangC.H., Badiwala M.V., Mickle D.A., Weisel R.D., Fedak P.W., StewartD.J., Kutryk M.J.: C-reactive protein attenuates endothelial progenitorcell survival, differentiation, and function: further evidence ofa mechanistic link between C-reactive protein and cardiovasculardisease. Circulation, 2004; 109: 2058-2067
  Google Scholar
• 32. Zdrojewski T., Chwojnicki K., Bandosz P., Konarski R., WyrzykowskiB.: Distribution of C-reactive protein and its relation to arterialhypertension in a country representing a high-risk region forcardiovascular diseases. Blood Press., 2006: 15: 20-26
  Google Scholar
• 33. Zhao Y., Wang R., Ma X., Yan X., Zhang Z., He X., He J.: Distributionof C-reactive protein and its association with cardiovascularrisk factors in a population-based sample of Chinese. Dis. Markers,2010; 28: 333-342
  Google Scholar

Pełna treść artykułu